insights_auto
Zašto je DRUG skočio 4,87%?
Istražite detaljnijechevron_right
DRUG:CNSX
Bright Minds Biosciences Inc
77,10 CAD
arrow_upward
+4,87%(+3,58) 1D
9. lis, 16:00:00 GMT -4 · CAD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za DRUG...
Otvori
76,13 CAD
Najviša
77,76 CAD
Najniža
76,13 CAD
Trž. kap.
760,52 mil.
Prosj. kol.
865,00
Količina
0,00
52-tjed. najviša
170,00 CAD
52-tjed. najniža
68,02 CAD
EPS
−2,90 CAD
Broj djelatnika
26
Otvori
76,13 CAD
Najviša
77,76 CAD
Najniža
76,13 CAD
Trž. kap.
760,52 mil.
Prosj. kol.
865,00
Količina
0,00
52-tjed. najviša
170,00 CAD
52-tjed. najniža
68,02 CAD
EPS
−2,90 CAD
Broj djelatnika
26
Vijesti
Iz web-izvora i od partnera za vijesti
Naslovi.net
·
prije 1 sat
Wall Street: Micron gubitnik dana, samo Dow Jones u plusu
Inc.com
·
prije 8 minuta
The S&P 500’s Bull Market Just Turned 4. History Says the Next Year Is What Matters Most
TradingView
·
prije 36 minuta
Nasdaq Futures Sink, Dow Rises Premarket As AI Chip Stocks Wobble Ahead Of Big Bank Earnings: MU, SNDK, NVTS, NVDA, SPCX, ASTS, UNH, V Stocks In Focus
MarketBeat
·
prije 32 minute
Anterix Inc. (NASDAQ:ATEX) Stock Has Average Target Price of $120.00 According to Brokerages
Profil
Bright Minds Biosciences is an American pharmaceutical company which is developing serotonin 5-HT₂ receptor agonists for potential medical use.
It has a particular focus on serotonin 5-HT2C receptor agonists, for instance to treat rare epilepsies and other conditions. Another area of focus for the company is serotonergic psychedelics and non-hallucinogenic psychoplastogens.
The company was co-founded by Ian McDonald and Gideon Shapiro. The lead scientist at Bright Minds Biosciences was previously Alan Kozikowski. Bright Mind Biosciences was founded in 2017 and its headquarters are in New York City, New York. Wikipedia
Bright Minds Biosciences Inc – informacije